September 30, 2010 – A specialized partner program was recently launched to enable select top healthcare institutions to provide advanced training in hemodynamic support and complex patient management.
The latest USpella update, announced by Abiomed at last week’s Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium, will better facilitate heart muscle recovery. The update provided data for 352 patients after prophylactic Impella-supported revascularization and emergent Impella support.
Data revealed that there was a significant reduction (59 percent) in the 30-day mortality rate in the group that received Impella before revascularization. Additionally, 90 percent of the USpella survivors in the emergent care group recovered their native cardiac function and were discharged with their own heart.
Heart muscle recovery was defined as an improvement of the heart muscle function that enables a patient to sustain quality of life at home.
“Treating emergent care patients in a timely and effective manner is an ongoing clinical challenge for many healthcare institutions. Within five years after a first heart attack, 33 percent of men and 43 percent of women die, emphasizing the need to establish heart recovery programs that can provide treatment that allows the heart muscle to recover,” said Michael R. Minogue, chairman, president and CEO, Abiomed. “This collaborative program will educate healthcare institutions across the U.S. on the value of treating patients with emergent hemodynamic support to allow earlier intervention that achieves the outcome of heart muscle recovery for their cardiac care programs. We are thrilled to announce PinnacleHealth as the first institution to partner with us on this program.”
PinnacleHealth operates five primary care facilities as well as a network of family practice and urgent care centers, managed care entities, home healthcare, hospice, and an array of other healthcare services.
The selected institutions will participate in the partner program by establishing protocols to improve heart muscle recovery for emergent cardiac care patients. These hospitals will be established as leading training centers focused on educating other institutions on the importance of heart muscle recovery and treating hemodynamically unstable patients with emergent revascularization.
For more information: www.abiomed.com
June 19, 2024 
